These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 1991803)

  • 1. Determination of plasma calcitonin gene-related peptide concentrations by a new immunochemiluminometric assay in normal persons and patients with medullary thyroid carcinoma and other neuroendocrine tumors.
    Carter WB; Taylor RL; Kao PC; Heath H
    J Clin Endocrinol Metab; 1991 Feb; 72(2):327-35. PubMed ID: 1991803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CGRP radioreceptor assay: a new diagnostic tool for medullary thyroid carcinoma.
    Wimalawansa SJ
    J Bone Miner Res; 1993 Apr; 8(4):467-73. PubMed ID: 8475796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcitonin gene-related peptide as a tumor marker for medullary thyroid carcinoma.
    Takami H; Ito K
    Int Surg; 1992; 77(3):181-5. PubMed ID: 1399365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ghrelin in human medullary thyroid carcinomas.
    Morpurgo PS; Cappiello V; Verga U; Vicentini L; Vaghi I; Lauri E; Nebuloni M; Beck-Peccoz P; Spada A
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):437-41. PubMed ID: 16181236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcitonin gene-related peptide and calcitonin as tumour markers in MEN 2 family screening.
    Schifter S
    Clin Endocrinol (Oxf); 1989 Mar; 30(3):263-70. PubMed ID: 2574082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma.
    Barbot N; Calmettes C; Schuffenecker I; Saint-André JP; Franc B; Rohmer V; Jallet P; Bigorgne JC
    J Clin Endocrinol Metab; 1994 Jan; 78(1):114-20. PubMed ID: 7904611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcitonin, calcitonin gene-related peptide, and gastrin-releasing peptide in familial thyroid medullary carcinoma.
    Månsson B; Ahrén B; Nobin A; Böttcher G; Sundler F
    Surgery; 1990 Feb; 107(2):182-6. PubMed ID: 2300897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated plasma calcitonin gene-related peptide and the symptoms associated with medullary thyroid cancer.
    Rubinstein C; Fletcher DR; Shulkes A; Hardy KJ
    Aust N Z J Surg; 1992 Nov; 62(11):892-6. PubMed ID: 20169709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of pentagastrin test for preoperative differential diagnosis between C-cell hyperplasia and medullary thyroid carcinoma in patients with moderately elevated basal calcitonin levels.
    Milone F; Ramundo V; Chiofalo MG; Severino R; Paciolla I; Pezzullo L; Lombardi G; Colao A; Faggiano A
    Clin Endocrinol (Oxf); 2010 Jul; 73(1):85-8. PubMed ID: 20039894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basal and stimulated release of calcitonin gene-related peptide (CGRP) in patients with medullary thyroid carcinoma.
    Mason RT; Shulkes A; Zajac JD; Fletcher AE; Hardy KJ; Martin TJ
    Clin Endocrinol (Oxf); 1986 Dec; 25(6):675-85. PubMed ID: 3498561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Measurement of plasma calcitonin gene-related peptide (CGRP) level in patients with thyroid disease].
    Takami H; Shikata J; Ozaki O; Mimura T; Ito K
    Nihon Geka Gakkai Zasshi; 1990 Mar; 91(3):401-6. PubMed ID: 2359396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical usefulness of a new chemiluminescent two-site immunoassay for human calcitonin.
    Grauer A; Raue F; Ziegler R
    Exp Clin Endocrinol Diabetes; 1998; 106(4):353-9. PubMed ID: 9792470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. Groupe d'Etudes des Tumeurs a Calcitonine (GETC).
    Cohen R; Campos JM; Salaün C; Heshmati HM; Kraimps JL; Proye C; Sarfati E; Henry JF; Niccoli-Sire P; Modigliani E
    J Clin Endocrinol Metab; 2000 Feb; 85(2):919-22. PubMed ID: 10690910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Radioimmunoassay of the calcitonin gene-related peptide and its measurement in the plasma of patients with medullary thyroid carcinoma and in the cerebrospinal fluid of normal subjects].
    Kim S; Morimoto S; Fukuo K; Hironaka T; Koh E; Shiraishi T; Onishi T; Kumahara Y; Kawai Y; Shiotani Y
    Nihon Naibunpi Gakkai Zasshi; 1987 Jul; 63(7):884-93. PubMed ID: 3500074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcitonin gene-related peptide: possible tumor marker for medullary thyroid cancer.
    Poston GJ; Seitz PK; Townsend CM; Alexander RW; Rajaraman S; Cooper CW; Thompson JC
    Surgery; 1987 Dec; 102(6):1049-54. PubMed ID: 3500524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of cytosolic free calcium concentration in the secretion of calcitonin gene-related peptide and calcitonin from medullary thyroid carcinoma cells.
    Haller-Brem S; Muff R; Petermann JB; Born W; Roos BA; Fischer JA
    Endocrinology; 1987 Oct; 121(4):1272-7. PubMed ID: 3498624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can sporadic medullary thyroid carcinoma be biochemically predicted? Prospective analysis of 66 operated patients with elevated serum calcitonin levels.
    Iacobone M; Niccoli-Sire P; Sebag F; De Micco C; Henry JF
    World J Surg; 2002 Aug; 26(8):886-90. PubMed ID: 12016469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating levels of calcitonin gene-related peptide in patients with medullary thyroid carcinoma.
    Kim S; Morimoto S; Kawai Y; Koh E; Onishi T; Ogihara T
    J Clin Chem Clin Biochem; 1989 Jul; 27(7):423-7. PubMed ID: 2794874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved diagnostic methods in the follow-up of medullary thyroid carcinoma by highly specific calcitonin measurements.
    Engelbach M; Görges R; Forst T; Pfützner A; Dawood R; Heerdt S; Kunt T; Bockisch A; Beyer J
    J Clin Endocrinol Metab; 2000 May; 85(5):1890-4. PubMed ID: 10843170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of calcitonin and calcitonin gene-related peptide mRNA refines the management of patients with medullary thyroid cancer and may replace calcitonin-stimulation tests.
    Camacho CP; Lindsey SC; Melo MC; Yang JH; Germano-Neto F; Valente Fde O; Lima TR; Biscolla RP; Vieira JG; Cerutti JM; Dias-da-Silva MR; Maciel RM
    Thyroid; 2013 Mar; 23(3):308-16. PubMed ID: 23259706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.